Morgan Stanley Abvc Biopharma, Inc. Transaction History

Morgan Stanley

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.9 - $2.93 $1,314 - $4,277	-1,460 Closed	0 $0
Q1 2022 Oct 27, 2022	BUY	$2.18 - $3.72 $3,182 - $5,431	1,460 New	1,460 $4,000
Q1 2022 May 13, 2022	SELL	$2.18 - $3.72 $56 - $96	-26 Reduced 1.75%	1,460 $4,000
Q4 2021 Feb 14, 2022	BUY	$2.15 - $6.03 $3,194 - $8,960	1,486 New	1,486 $5,000

Ticker ABVC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,632,300
Market Cap $22.8M
Description
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major dep...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.